Sonja Smith

Sonja Smith

Auto-generated profile, based on publicly available information

Sonja Smith

Institute for Experimental Cancer Research in Pediatrics, Goethe University, Frankfurt am Main, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2020 in Science Signaling
Verified
Journal Article
Closed access
PDF file
CKChristos Karathanasis
Christos Karathanasis
JMJuliane Medler
Juliane Medler
FFFranziska Fricke
Franziska Fricke
SSSonja Smith
Sonja Smith
SMSebastian Malkusch
Sebastian Malkusch
MHMike Heilemann
Mike Heilemann
Ligand binding triggers the oligomerization of TNFR1 monomers and dimers into trimers and higher-order oligomers.

13 May 2020 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
NWNadine Weinelt
Nadine Weinelt
CKChristos Karathanasis
Christos Karathanasis
SSSonja Smith
Sonja Smith
JMJuliane Medler
Juliane Medler
SMSebastian Malkusch
Sebastian Malkusch
SWSjoerd van Wijk
Sjoerd van Wijk
TNFR1 is a crucial regulator of NF-ĸB-mediated proinflammatory cell survival responses and programmed cell death (PCD). Deregulation of TNFα- and TNFR1-controlled NF-ĸB signaling underlies major diseases, like cancer, inflammation, and autoimmune diseases. Therefore, although being routinely used, antagonists of TNFα might also affect TNFR2-mediated processes, so that alternative approaches to directly antagonize TNFR1 are beneficial. Here, we apply quantitative single-molecule localization microscopy (SMLM) of TNFR1 in physiologic cellular settings to validate and characterize TNFR1 inhibitory substances, exemplified by the recently described TNFR1 antagonist zafirlukast. Treatment of TNFR1-mEos2 reconstituted TNFR1/2 knockout mouse embryonic fibroblasts (MEFs) with zafirlukast inhibited both ligand-independent preligand assembly domain (PLAD)-mediated TNFR1 dimerization as well as TNFα-induced TNFR1 oligomerization. In addition, zafirlukast-mediated inhibition of TNFR1 clustering was accompanied by deregulation of acute and prolonged NF-ĸB signaling in reconstituted TNFR1-mEos2 MEFs and human cervical carcinoma cells. These findings reveal the necessity of PLAD-mediated, ligand-independent TNFR1 dimerization for NF-ĸB activation, highlight the PLAD as central regulator of TNFα-induced TNFR1 oligomerization, and demonstrate that TNFR1-mEos2 MEFs can be used to investigate TNFR1-antagonizing compounds employing single-molecule quantification and functional NF-ĸB assays at physiologic conditions.